In MetS, the supplementation with inositol, either alone or with α-lipoic acid, may be considered a therapeutic strategy in women since it contributes to increasing both high-density lipoprotein cholesterol (HDL-c) and HOMA index, as well as serum glucose, insulin, blood pressure, triglycerides, and total cholesterol [54,55]. This evidence concerns the gene INS and metabolic syndrome.